Aging & Longevity

Di-n-butyl phthalate induces NF-κB-mediated senescence-associated secretory phenotype to promote epithelial proliferation, epithelial-mesenchymal transition, and benign prostatic hyperplasia.

TL;DR

Di-n-butyl phthalate induces NF-κB-mediated senescence-associated secretory phenotype to promote epithelial proliferation, epithelial-mesenchymal transition, and benign prostatic hyperplasia through IL-8/CXCR2 signaling.

Key Findings

DBP exposure promoted benign prostatic hyperplasia in a Sprague-Dawley rat model.

  • A DBP-exposed SD rat model was established to confirm the promoting effect of DBP on BPH.
  • Both in vivo and in vitro studies confirmed that inhibition of CXCR2 reverses the promoting effect of DBP exposure on BPH.
  • The rat model served as the primary in vivo system for validating mechanistic findings from cell culture experiments.

DBP exposure promoted cellular senescence in BPH-1 cells, as evidenced by secretion of senescence-associated secretory phenotype (SASP)-related factors.

  • Transcriptome sequencing analysis of BPH-1 cells after DBP exposure revealed that DBP promotes cellular senescence.
  • The senescence was characterized by the secretion of SASP-related factors.
  • The NF-κB pathway was identified as mediating DBP-induced SASP.

DBP-induced SASP primarily promotes cell proliferation and epithelial-mesenchymal transition (EMT) through the release of IL-8.

  • Co-culture of DBP-exposed cells with unexposed BPH-1 cells showed that DBP-induced SASP promotes cell proliferation and EMT.
  • IL-8 was identified as the primary SASP factor responsible for these effects.
  • IL-8 exerts its effects by binding to CXCR2 receptor on unexposed cells.

Inhibition of CXCR2 reversed the promoting effects of DBP exposure on BPH both in vivo and in vitro.

  • Both in vivo and in vitro studies confirmed that CXCR2 inhibition reverses DBP's promotion of BPH.
  • This finding validates the IL-8/CXCR2 axis as a key mechanistic pathway linking DBP exposure to BPH progression.
  • CXCR2 inhibition reversed effects on both epithelial proliferation and EMT.

DBP, a prevalent environmental endocrine disruptor, is associated with various genitourinary diseases including BPH.

  • DBP is described as a 'prevalent environmental endocrine disruptor.'
  • The study establishes a mechanistic link between DBP exposure and BPH progression.
  • These findings provide 'new insights into the mechanisms by which DBP exposure contributes to BPH progression.'

Have a question about this study?

Citation

Li T, Zhang Y, Zhou X, Ji S, Zhou Z, Wang W, et al.. (2026). Di-n-butyl phthalate induces NF-κB-mediated senescence-associated secretory phenotype to promote epithelial proliferation, epithelial-mesenchymal transition, and benign prostatic hyperplasia.. Environment international. https://doi.org/10.1016/j.envint.2026.110085